1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Indaptus Therapeutics agreed on September 8, 2026 to sell 20,338,974 shares of common stock to purchasers in a private placement for aggregate gross proceeds of about $24.0 million before offering expenses. The company plans to use the proceeds for working capital, research and development, and general corporate purposes, possibly including early-stage work on a neurotechnology device for sleep-related conditions. The shares are unregistered, and the company must later file a resale registration statement, which could add shares to the market.
Shares sold: 20,338,974 shares of common stock at a price equal to the Nasdaq Minimum Price plus $0.015 per share
Gross proceeds: approximately $24.0 million before offering expenses
Closing: subject to customary conditions, no later than the fifteenth business day after September 8, 2026
Shares were sold under Section 4(a)(2) and/or Regulation S and are subject to transfer restrictions
Group 1 Automotive agreed to sell $1.25 billion of senior unsecured notes in two tranches, due 2032 and 2035, with expected net proceeds of about $1,236.0 million and closing expected on September 22, 2026. The company plans to use the proceeds, with cash on hand, to fund its pending purchase of dealership assets and related real estate from Hennessy Automobile Companies, and the filing says the 2032 notes must be redeemed if that acquisition is not completed by the outside date.
$625.0 million of 6.250% senior notes due 2032 and $625.0 million of 6.625% senior notes due 2035, sold at par
Expected net proceeds of approximately $1,236.0 million; closing expected September 22, 2026
If the Hennessy Acquisition is not consummated by January 6, 2027, or any extended date, the 2032 notes must be redeemed at 100% of issue price plus accrued interest
Affiliates of certain initial purchasers are lenders under the company's revolving credit facility and will receive a portion of the net proceeds
PAVmed Inc. signed a Sales Agreement with A.G.P./Alliance Global Partners that lets it sell common stock through the agent from time to time, up to $9,400,000 of shares under its current prospectus supplement. The company says it plans to use net proceeds for working capital and general corporate purposes, and the sales would dilute existing shareholders.
Maximum offering under the current prospectus supplement is $9,400,000 of common stock.
The agent's commission is 3.0% of aggregate gross sales prices, plus legal cost reimbursements of up to $65,000 at signing.
Shares are offered under a Form S-3 shelf registration declared effective April 15, 2025, with a prospectus supplement dated September 9, 2026.
Either party may terminate the agreement on ten business days' written notice.
HCW Biologics filed an amended preliminary proxy statement on September 9, 2026, after the board decided not to seek stockholder approval of Proposal No. 2, an amended performance-based equity plan for eligible officers, directors and employees. The amendment also changes the Special Meeting date, the record date and certain other dates.
Proposal No. 2, an amended performance-based equity plan, was removed from the proxy after stockholder feedback.
The amendment changes the date of the Special Meeting of Stockholders and the record date.
The original preliminary proxy statement was filed with the SEC on September 8, 2026.
No other substantive changes were made to the original preliminary proxy statement, per the filing.
Plains All American Pipeline priced $700 million of 6.75% Series A and $800 million of 7.00% Series B junior subordinated notes due 2056, expected to close September 14, 2026. The company plans to use the proceeds, with cash on hand and commercial paper, to redeem all of its outstanding Series A and Series B preferred units. The filing replaces preferred units with junior debt but does not state the effect on earnings or distributions.
$700 million of 6.75% Series A and $800 million of 7.00% Series B junior subordinated notes due 2056 priced, with closing expected September 14, 2026
Proceeds, cash on hand and commercial paper to redeem all 58,411,908 Series A preferred units and all 800,000 Series B preferred units
Series A units redeemed at $28.875 per unit (110% of $26.25 par) on or about September 14, 2026; Series B at $1,000 par on or about October 9, 2026
STAAR Surgical appointed David Bailey, its former President and Chief Executive Officer, as Chief Commercial Officer effective September 8, 2026. He reports to CEO Warren Foust, and the filing sets out his base salary, bonus target and equity awards, which shareholders can review in the offer letter filed as Exhibit 10.1.
Appointed Chief Commercial Officer effective September 8, 2026; reports to Warren Foust, President and CEO
Base salary at an annual rate of CHF 462,825 (approximately $575,000), with a 2026 target bonus of 60% of base salary, prorated
Initial RSU grant valued at $850,000 vesting over three years, plus a 2026 long-term incentive award valued at $1,400,000, prorated
Mr. Bailey previously served as STAAR's President and CEO from 2001 to 2008 and as President, International Operations, from 2008 to 2011
Principal Financial Group and two subsidiaries entered into an amended and restated five-year credit facility with Wells Fargo as administrative agent, refinancing the company's existing revolving facility dated October 18, 2022. The facility allows borrowing of up to $900 million, with a commitment termination date of September 9, 2031, and no borrowings are currently outstanding; this is a routine financing update with no new debt drawn.
Facility allows borrowing of up to $900 million, expandable to a maximum of $1.3 billion subject to conditions
Commitment termination date of September 9, 2031, with up to two 1-year extensions
No borrowings outstanding under the facility as of filing
Financial covenants include minimum Statutory Surplus of $2,885,208,297 and Total Debt to Total Capital ratio not exceeding 35%
Enbridge agreed with an underwriting syndicate led by RBC Capital Markets and CIBC Capital Markets to sell 38.9 million common shares at CDN$66.85 each, for gross proceeds of CDN$2.6 billion. The company plans to use the net proceeds to partially fund announced acquisitions and to create financial flexibility for future growth, which would add new shares outstanding for existing holders.
Offering of 38,900,000 common shares at CDN$66.85 per share, for aggregate gross proceeds of CDN$2.6 billion
Offering expected to close on or about September 14, 2026
Underwriters hold an option for up to 15% more shares, which would bring gross proceeds to about CDN$3.0 billion if fully exercised
Net proceeds intended to partially fund announced acquisitions and provide financial flexibility
Build-A-Bear Workshop's board declared a quarterly cash dividend of $0.23 per share on September 9, 2026, payable October 8, 2026 to holders of record at the close of business on September 24, 2026. The filing is a routine dividend announcement and does not report new financial results or change guidance. The accompanying press release notes fiscal 2025 total revenues of $529.8 million, the company's fifth consecutive year of record results.
Quarterly cash dividend of $0.23 per share declared September 9, 2026
Record date is September 24, 2026, at the close of business
Dividend payment date is October 8, 2026
Press release (Exhibit 99.1) cites fiscal 2025 total revenues of $529.8 million
Wrap Technologies amended the employment agreements of Chief Executive Officer Scot Cohen and President and Chief Operating Officer Jared Novick and approved performance restricted stock grants to each on September 2, 2026. The awards total 6,000,000 shares and vest only if the company's market capitalization meets thresholds from $150.0 million to $506.25 million, with part of the shares also tied to a stockholder vote to increase the equity plan's authorized shares. The filing also extends the post-termination exercise period on certain prior stock options from three months to 24 months.
Scot Cohen receives 4,000,000 performance restricted stock shares; Jared Novick receives 2,000,000, approved September 2, 2026.
Shares vest in tranches when market capitalization meets $150.0 million, $225.0 million, $337.5 million and $506.25 million for 45 consecutive trading days.
1,600,000 Cohen shares and 800,000 Novick shares are void if stockholders do not approve an equity plan increase by March 15, 2027.
Both employment agreements set a $200,000 annualized base salary and a two-year initial term, with 12-month automatic renewals.
Investar Holding Corp CEO John J. D'Angelo adopted a Rule 10b5-1 trading plan on September 4, 2026, to exercise stock options expiring in March 2027 and sell the resulting shares. The plan takes effect December 3, 2026, and expires on or before March 31, 2027, with trades reported on Form 4 filings.
Plan covers up to 16,952 stock options expiring in March 2027
Plan adopted September 4, 2026; effective December 3, 2026; expires on or before March 31, 2027
Company says D'Angelo continues to hold a significant number of fully-vested shares above ownership guidelines
KALA BIO's board set November 3, 2026 as the date of its next annual stockholders meeting. Stockholders who want to submit proposals for inclusion in the proxy materials, or nominate directors, must do so by September 19, 2026, because the meeting date moved by more than 30 days from the prior anniversary.
Annual meeting date set for November 3, 2026; the board set the date on September 9, 2026
Deadline for Rule 14a-8 stockholder proposals for proxy inclusion: September 19, 2026
Deadline for director nominations and other proposals under the By-Laws: September 19, 2026, at the company's Arlington, Massachusetts offices
Meeting time, location and voting matters will be detailed in the proxy statement
Candel Therapeutics furnished a September 2026 corporate presentation under Regulation FD, for use with investors and analysts. The deck restates Phase 3 results for aglatimagene in localized, intermediate- to high-risk prostate cancer, including extended follow-up data presented at AUA 2026, and reports cash and cash equivalents of $201.6 million as of June 30, 2026. The filing contains no new financial results or guidance.
Phase 3 trial (n=745) met its primary endpoint of disease-free survival, with a hazard ratio of 0.70 (95% CI 0.52 to 0.94; P=0.0155) in the intent-to-treat population.
Extended follow-up data (data cutoff March 15, 2026) showed prostate cancer-specific DFS hazard ratio of 0.61 (95% CI 0.44 to 0.85; P=0.0031).
Cash and cash equivalents were $201.6 million as of June 30, 2026, with expected runway into Q1 2028.
Financing includes a term loan facility with Trinity Capital of up to $130 million (October 2025) and a $100 million royalty funding agreement with RTW Investments (February 2026), subject to approval of aglatimagene in localized prostate c
Diversified Energy Company agreed on September 2, 2026 to acquire Birch Permian Holdings and related companies in a transaction with an aggregate purchase price of approximately $1.8 billion, including repayment of indebtedness. The deal adds about 46,000 net mineral acres in the Midland Basin plus midstream and water infrastructure, and is expected to close in the fourth quarter of 2026 subject to customary conditions. The company expects to fund roughly $1.5 billion through an asset-backed securitization, with the remainder from other sources including its revolving credit facility.
Aggregate purchase price of approximately $1.8 billion, subject to adjustments
Expected funding includes an asset-backed securitization of approximately $1.5 billion before closing
Merger Agreement requires a $50 million deposit; a $50 million termination fee applies in certain cases
Expected closing in the fourth quarter of 2026, subject to customary closing conditions
AT&T's Board increased its size from 10 to 11 members, effective September 8, 2026, and elected Fazal F. Merchant to fill the new seat. The Board determined Merchant is independent under New York Stock Exchange standards and appointed him to the Audit and Corporate Development and Finance Committees. The filing is administrative and does not report financial results or a change in leadership of the company.
Board size increased from 10 to 11 members, effective September 8, 2026
Fazal F. Merchant elected Director to fill the resulting vacancy
Merchant appointed to the Audit and Corporate Development and Finance Committees
Board determined Merchant is independent under NYSE standards
Culp reported first-quarter fiscal 2027 results for the period ended August 2, 2026, with net sales of $54.0 million, up 6.5% from a year earlier, and net income of $6.0 million, or $0.47 per diluted share, versus a net loss of $231 thousand a year earlier. Reported profit includes $6.9 million in tariff refunds, and excluding them the company shows an adjusted operating loss of $271 thousand, narrower than the $1.9 million adjusted loss a year ago. The company also cut net debt to $3.1 million from $10.9 million at fiscal year-end and expects break-even operating income in the second quarter.
Net sales $54.0 million, up 6.5%; bedding sales up 13.2% to $31.8 million, upholstery down 1.9% to $22.2 million
Net income $6.0 million, or $0.47 per diluted share, including $6.9 million in tariff refunds tied to the Supreme Court's February 2026 IEEPA ruling
Adjusted operating loss of $271 thousand, compared with an adjusted operating loss of $1.9 million a year earlier
Net debt fell to $3.1 million from $10.9 million at fiscal year-end; company expects break-even operating income in the second quarter
CooperCompanies said its strategic review is complete and the Board unanimously decided to retain CooperSurgical, while also expanding its share repurchase authorization from $2 billion to $3 billion. The same day it reported fiscal third-quarter results with revenue up 1% and non-GAAP diluted EPS up 4%, though GAAP EPS was lifted by a $307.2 million tax benefit.
Q3 revenue $1.066 billion, up 1%; non-GAAP diluted EPS $1.15, up 4% from $1.10
GAAP diluted EPS $2.24 versus $0.49, driven by a $307.2 million discrete tax benefit from a U.K. tax examination
Buyback authorization raised from $2 billion to $3 billion; about $1.5 billion remains available after $339.1 million repurchased in the quarter
Fiscal Q4 2026 non-GAAP diluted EPS guidance of $1.05 to $1.09; fiscal 2026 guidance of $4.51 to $4.55
Alico's board declared a fourth quarter fiscal 2026 cash dividend of $0.05 per share on September 8, 2026. Shareholders of record as of October 2, 2026 will receive payment on or around October 16, 2026, per the filing's stated expectation.
Dividend amount: $0.05 per share on outstanding common stock
In an investor presentation furnished under Regulation FD, Americold said its key operating metrics rose both year over year and sequentially in July and August 2026. The company closed its joint venture with EQT on August 31, 2026, which generated $1.15 billion of net proceeds used to pay down debt, and it reiterated full-year AFFO guidance of $1.26 to $1.32. For shareholders, the deal is a significant step in reducing leverage, and the company projects about $46 million in annual interest savings.
Occupancy, blended pricing and throughput all increased year over year in July and August, based on preliminary results that are subject to change.
The EQT joint venture closed August 31, 2026, with a total value of about $1.3 billion and a 70% EQT / 30% Americold ownership split.
Full-year AFFO guidance of $1.26 to $1.32 was reiterated, and net debt was about $4 billion at June 30, 2026.
On September 9, 2026, CenterPoint Energy and its subsidiaries Houston Electric, CERC and SIGECO replaced their existing revolving credit facilities with four new five-year facilities totaling $4.6 billion in aggregate commitments. The company reported that no termination penalties were incurred on the earlier facilities. The filing describes a refinancing of existing credit capacity rather than a change in the company's earnings or guidance.
CenterPoint Energy parent replaced its $2.4 billion facility, dated December 6, 2022, with a new $2.2 billion facility, with a request option for increases up to $2.5 billion.
Houston Electric replaced a $300 million facility with a new $1.0 billion facility; CERC replaced $1.05 billion with $1.1 billion; SIGECO replaced $250 million with $300 million.
The parent facility limits debt to consolidated capitalization to 67.5%, temporarily raised to 70% after certain natural disaster certifications.
JPMorgan Chase Bank, N.A. serves as administrative agent for the parent facility and will serve as agent for the other three facilities.
Rallybio's Chief Financial Officer, Jonathan Lieber, will move to part-time employment effective September 15, 2026, but will remain CFO and Principal Financial Officer with the same duties and authority. His employment will end when the pending business combination with Avenzo Therapeutics closes, unless it is terminated earlier.
Part-time transition effective September 15, 2026; he keeps the CFO and principal financial officer titles
Base salary of $420,000 after the transition, with benefit plan participation
No annual bonus for 2026 or any later year he is employed
Employment ends at the closing of the Avenzo merger agreement dated May 31, 2026; severance follows under his existing employment agreements
American Eagle Outfitters reported second-quarter fiscal 2026 results for the period ended August 1, 2026, with net revenue up 8% to $1.38 billion and diluted earnings per share of $0.79 versus $0.45 a year earlier. The quarter included a net $161 million operating benefit from tariff refunds, and the company set fiscal 2026 operating income guidance of $540 million to $550 million that includes that benefit. Aerie comparable sales rose 19% while American Eagle comparable sales fell 1%.
Net revenue of $1.38 billion rose 8%; comparable sales rose 6%, with Aerie up 19% and American Eagle down 1%.
Operating profit was $211 million versus $103 million last year, including a net $161 million tariff refund benefit.
Diluted EPS was $0.79 versus $0.45 last year.
Fiscal 2026 operating income guidance is $540 million to $550 million, inclusive of the net tariff refund benefit; third-quarter operating income is guided to $110 million to $115 million.
BJ's Restaurants, Inc. appointed Christopher W. Brandt and James D. White as independent directors, effective September 3, 2026. The Board's authorized seats rose from eight to ten under the company's bylaws, and the filing describes the new directors' backgrounds in restaurant marketing and public company leadership.
Effective September 3, 2026, Brandt and White joined the Board; Brandt serves on the Governance and Nominating Committee and White on the Compensation Committee.
Authorized directors increased from eight to ten under Article III, Section 2 of the Bylaws.
Brandt was President, Chief Brand Officer and Chief Marketing Officer at Chipotle Mexican Grill from 2018 to 2026.
White was Chair, President and Chief Executive Officer of Jamba Juice from 2008 to 2016.
Amazon's board elected cybersecurity executive Kevin R. Mandia as a director on September 8, 2026, and appointed him to the Audit Committee and Security Committee. He receives a restricted stock unit award for 4,086 shares that vests in three equal annual installments starting November 15, 2027, if he continues to serve. The change adds a director with cybersecurity leadership experience to oversight of audit and security matters.
Elected as director on September 8, 2026, and appointed to the Audit Committee and Security Committee
Restricted stock unit award for 4,086 shares, vesting in three equal annual installments beginning November 15, 2027
Mr. Mandia previously served as CEO of Mandiant, Inc. from June 2016 to July 2024 and is CEO of Armadin, Inc.
Filing also discloses that an employee, Kristin Mandia, is his sister-in-law, with an annual salary of $185,000
Hagerty, Inc. announced that its majority holder, Hagerty Holding Corp., plans an underwritten secondary offering of 8,250,000 shares of Hagerty Class A common stock, with a 30-day option for underwriters to buy up to 1,237,500 more. Hagerty will not receive any proceeds from the sale, so the offering does not raise capital for the company, though Hagerty will bear its own expenses of the offering.
Selling stockholder Hagerty Holding Corp. intends to offer 8,250,000 Class A shares.
Underwriters have a 30-day option to purchase up to 1,237,500 additional shares.
Hagerty receives no proceeds; Hagerty Holding Corp. bears its underwriting discount and the company bears remaining expenses.
Wells Fargo Securities and J.P. Morgan are lead bookrunning managers, per the September 9, 2026 press release.
Selling stockholders affiliated with TDR Capital agreed to sell 14,000,000 Target Hospitality common shares at $18.50 per share in an underwritten offering, and the company will not receive any of the proceeds. Separately, the company agreed to buy back shares from the underwriters for approximately $30 million, funded with cash on hand and ABL Credit Facility borrowings, with the closing expected on September 10, 2026.
14,000,000 shares offered by Arrow Holdings S.à r.l. and MFA Global S.à r.l. at $18.50 per share, for approximately $259,000,000 in gross proceeds to the selling stockholders
Company will not receive any proceeds from the offering
Company to repurchase shares from the underwriters for approximately $30,000,000, to be held as treasury shares and funded with cash on hand and ABL Credit Facility borrowings
Underwriters have a 30-day option to buy up to 2,100,000 additional shares; closing is expected on September 10, 2026
Enbridge said a wholly-owned subsidiary has signed a definitive agreement to acquire Tallgrass Energy's crude oil transportation, gathering, storage and terminaling business for U.S.$2.55 billion in cash, subject to customary closing adjustments. Enbridge expects the deal to be accretive to distributable cash flow per share in the first full year of ownership, and says its 2026 financial guidance is not materially affected because closing is expected later in 2026.
Cash consideration of U.S.$2.55 billion, representing an estimated acquisition multiple of 10-11x forward enterprise value to EBITDA.
Assets include 75% of Pony Express Pipeline, 51% of Powder River Gateway system, and about 8.4 million barrels of storage across nine crude terminals.
PXP2 expansion of U.S.$0.3 billion is expected to increase Pony Express capacity to about 515 kbpd, with service expected in late 2027.
Closing is expected later in 2026, subject to regulatory approvals including Federal Trade Commission clearance; an equity offering will partially fund the deal.
Kewaunee Scientific reported first-quarter fiscal 2027 sales of $66.3 million, down 6.7% from a year earlier, and diluted earnings per share of $0.58 versus $1.04. Pre-tax earnings fell 34.7%, partly due to extra compensation expense from settling long-term incentive awards in cash, which the company says will not recur. Backlog rose from April 30, 2026 but remained below its level a year earlier.
Sales were $66.3 million versus $71.1 million; net earnings attributable to the company were $1.7 million versus $3.1 million.
Pre-tax earnings were $2.6 million versus $3.9 million, a decrease of 34.7%.
Backlog rose to $169.0 million on July 31, 2026, from $165.9 million on April 30, 2026, but was $205.0 million on July 31, 2025.
Long-term debt excluding the sale-leaseback obligation fell to $13.8 million from $15.1 million on April 30, 2026.
Director Frederick J. Elmy retired from the RBC Bearings board on September 3, 2026, the same day as the annual stockholder meeting. Stockholders elected the company's director nominees, ratified Ernst & Young LLP as auditor for fiscal 2027, and approved executive pay on an advisory basis, so these are routine governance outcomes.
Frederick J. Elmy retired from the Board of Directors on September 3, 2026.
Dr. Michael J. Hartnett received 27,410,015 for votes and Dolores J. Ennico received 21,681,115 for votes in the Class III director election.
Ernst & Young LLP was ratified as independent auditor for fiscal year 2027 with 29,148,374 for votes against 310,987.
Advisory say-on-pay proposal received 26,967,486 for votes against 1,172,452.
Essential Properties Realty Trust promoted Chief Operating Officer R. Max Jenkins to President and Chief Operating Officer, expanded Robert W. Salisbury's role to include Chief Strategy Officer, and named Craig Vachris Chief Investment Officer after A Joseph Peil's employment ended September 8, 2026. CEO Peter M. Mavoides continues in his role and signed a new employment agreement, which matters to shareholders because it reshapes the senior team that runs investments and strategy.
Jenkins appointed President and Chief Operating Officer; Mavoides remains Chief Executive Officer, with amended employment agreements effective September 8, 2026 running through March 31, 2031
Jenkins and Salisbury received promotion grants of long-term incentive plan units with a target grant date value of $2,000,000, vesting 50% at three and four years
Craig Vachris, with more than 20 years of commercial real estate and net lease experience, named Executive Vice President and Chief Investment Officer
Peil's employment ended September 8, 2026, and he is eligible for severance for a termination without cause
Fortune Brands Innovations appointed Peter G. Clifford as Executive Vice President and Chief Financial Officer, effective September 21, 2026. Interim CFO Ashley George will return to her prior role as Senior Vice President, Finance. The filing also sets out Clifford's pay and inducement equity awards, which are granted outside the company's 2022 Long-Term Incentive Plan.
Clifford, 56, was CFO of Filtration Group Corporation until August 2026.
Base salary of $700,000, annual bonus target of 90% of base salary, and long-term incentive target of $1,950,000.
Inducement awards: performance-based RSUs on 130,000 shares and stock options on 65,000 shares, to be granted September 28, 2026.
Ashley George, Interim CFO, will become Senior Vice President, Finance.
Research Solutions reported fiscal 2026 net income of $2.8 million, or $0.09 per diluted share, up from $1.3 million, or $0.04, a year earlier, while total revenue fell to $48.3 million from $49.1 million. Fourth-quarter revenue of $12.1 million and net income of $666,000 were both below the prior-year quarter, which included a $1.1 million favorable Scite earnout adjustment, so shareholders see a mixed picture of annual profit growth alongside shrinking sales.
Fiscal 2026 net income was $2.8 million, or $0.09 per diluted share, versus $1.3 million, or $0.04, in fiscal 2025.
Fiscal 2026 total revenue was $48.3 million versus $49.1 million; transaction revenue fell to $27.5 million from $30.1 million.
Fourth-quarter net income was $666,000, or $0.02 per diluted share, versus $2.4 million, which included a $1.1 million Scite earnout adjustment.
B2B ARR rose 14.1% to $16.2 million, and total ARR rose 7.8% to $22.5 million as of June 30, 2026.
Luxfer Holdings said the U.S. Hart-Scott-Rodino waiting period for its proposed acquisition by Double Eagle Acquisition Buyer, Inc., a holding company owned by funds managed by Wynnchurch Capital, expired at 11:59 p.m. EDT on September 8, 2026. That clears one of the closing conditions, but the deal still requires shareholder approval, certain other regulatory approvals and High Court sanction in England and Wales.
HSR waiting period expired at 11:59 p.m. EDT on September 8, 2026.
The transaction is a scheme of arrangement under Part 26 of the U.K. Companies Act 2006, under a Transaction Agreement dated July 26, 2026.
Remaining conditions include shareholder approval and certain other regulatory approvals.
A preliminary proxy statement was filed with the SEC on August 26, 2026.
Lakeland Industries reported fiscal second quarter 2027 results for the period ended July 31, 2026. Net sales fell 4.5% year over year to $50.1 million, and the company posted a net loss of $4.9 million, compared with net income of $0.8 million a year earlier. The loss included a non-cash goodwill impairment of approximately $3.2 million tied to LHD Germany, partly offset by a $1.9 million gain on lease settlement.
Net sales were $50.1 million versus $52.5 million in Q2 FY26, a decrease of 4.5%; gross margin was 37.0% versus 35.9%.
Net loss was $4.9 million, or $0.50 per share, versus net income of $0.8 million, or $0.08 per share, in Q2 FY26.
Adjusted EBITDA was $1.4 million versus $5.0 million a year earlier; adjusted EBITDA excluding FX was $2.7 million versus $5.1 million.
As of July 31, 2026, the company had $24.9 million outstanding under its revolving credit facility and was in compliance with its debt covenants.
Navan reported second-quarter fiscal 2027 results for the quarter ended July 31, 2026, with revenue up 35% year-over-year to $233 million. It raised its fiscal 2027 total revenue outlook to $927 million to $933 million, while its GAAP loss from operations widened to $26 million from $12 million a year earlier. Shareholders get higher revenue and guidance, though the GAAP operating loss grew and the GAAP net loss narrowed to $29 million from $39 million.
Q2 GAAP net loss was $29 million, compared with $39 million in the year-earlier quarter; non-GAAP net income was $14 million, compared with a non-GAAP net loss of $8 million.
Fiscal 2027 total revenue outlook raised to $927 million to $933 million; non-GAAP income from operations expected at $82 million to $86 million.
Third-quarter fiscal 2027 total revenue expected at $253 million to $255 million.
Navan acquired Smartrips, a Brazilian travel management company, and BoomPop, an AI-native meetings and events platform.
8x8 posted an investor presentation on September 9, 2026, with first-quarter fiscal 2027 results and fiscal 2027 guidance given as of August 4, 2026. Revenue rose to a record, but the company's own guidance implies lower non-GAAP operating margin and operating profit for fiscal 2027 than fiscal 2026, and the term loan is due in August 2027.
Q1 fiscal 2027 total revenue of $190M, up 4.9% year over year; GAAP operating margin 2.3% and non-GAAP operating margin 9.9%.
Aviat Networks disclosed that on September 2, 2026, its subsidiary Aviat U.S., Inc. received orders from an existing North America customer worth $35 million to $40 million. The company said future deployment timing, scale and scope remain subject to the customer's internal planning and market conditions, so the orders do not guarantee the full amount will be realized as revenue on a fixed schedule.
Orders of $35 million to $40 million received September 2, 2026 by subsidiary Aviat U.S., Inc.
Customer is an existing North America customer; the filing does not name it.
Future deployments depend on the customer's internal planning and market conditions.
Filed under Regulation FD (Item 8.01, Other Events) on September 9, 2026, signed by CFO Andrew C. Schmidt.
Century Therapeutics added Joseph Truitt, chief executive of iECURE, Inc., as a director effective September 9, 2026, increasing the board from six to seven members. Truitt will also serve on the Compensation Committee and receive standard non-employee director pay, including a stock option award and an annual cash retainer, so the appointment adds a board member with biotechnology executive experience.
Truitt appointed effective September 9, 2026 as a Class I director with a term expiring at the 2028 Annual Meeting of Stockholders
Board size increased from six to seven directors; Truitt will serve on the Compensation Committee
Initial option grant of 148,000 shares of common stock, vesting in equal monthly installments over 36 months, plus an annual cash retainer of $40,000
Board determined Truitt is independent under Nasdaq listing rules
At an extraordinary general meeting on September 8, 2026, shareholders approved extending Andretti Acquisition Corp. II's deadline to complete a business combination from September 9, 2026 to September 9, 2027, or an earlier date set by the board. Holders of 15,776,190 Public Shares redeemed them for cash, an aggregate of approximately $171.69 million, leaving 7,223,810 Public Shares outstanding.
Extension Amendment vote: 23,241,840 for, 2,775,781 against, 0 abstentions
Meeting Redemptions: 15,776,190 Public Shares at approximately $10.88 per share, about $171.69 million in total
On September 8, 2026, the Company and Sponsor signed a new non-redemption agreement covering up to 650,000 Non-Redeemed Shares
Sponsor converted 5,749,999 Class B shares into Class A; after the conversion and redemptions there are 13,733,809 Class A and one Class B ordinary share outstanding
Joby Aviation's Board appointed Sergey Novikov, the company's Controller since June 2021, as Principal Accounting Officer on September 2, 2026, effective immediately. The filing states his pay and other arrangements continue unchanged from before the promotion, so the change is administrative and does not alter compensation terms disclosed in the filing.
Board appointed Sergey Novikov as Principal Accounting Officer on September 2, 2026, effective immediately
Novikov has been Controller since June 2021 and was acting principal accounting officer from December 13, 2024 through May 29, 2025
Compensatory arrangements continue as in effect before the promotion; he will sign the company's standard indemnification agreement
Filing states no arrangements or understandings tied to the appointment and no related-party transactions under Item 404(a)
Gloo Holdings reported second-quarter results for the three months ended July 31, 2026, with revenue of $46.6 million, up from $16.2 million a year earlier, and a net loss of $21.2 million, narrowed from $44.1 million. The company raised its fiscal 2026 revenue guidance to $200 million and reiterated that it expects Adjusted EBITDA profitability in the fourth quarter of 2026, which points to improving results for shareholders while losses remain.
Q2 2026 revenue was $46.6 million, up 188% from $16.2 million, and above guidance of $44.0 million.
Net loss narrowed to $21.2 million from $44.1 million; Adjusted EBITDA was negative $8.3 million, versus guidance of negative $8.5 million.
Fiscal 2026 revenue guidance raised to $200 million; third-quarter revenue expected at $55 million and Adjusted EBITDA at negative $3.5 million.
Cash and cash equivalents were $39.3 million at July 31, 2026, down from $57.3 million at January 31, 2026.
Wealthfront reported fiscal second quarter 2027 results for the period ended July 31, 2026. Revenue rose 1% year-over-year to $91.9 million, but GAAP diluted net income fell 49% to $17.6 million and diluted EPS fell to $0.10 from $0.24, mainly due to higher stock-based compensation tied to awards recognized after the December 2025 IPO. Total Platform Assets grew 12% to $99.0 billion, and the company said it surpassed $100 billion at the end of August.
Total revenue $91.9 million, up 1% from $91.1 million; GAAP net income $17.6 million versus $34.7 million
Stock-based compensation expense $16.4 million versus $1.6 million a year earlier; adjusted EBITDA $38.1 million, down 15%
Total Platform Assets $99.0 billion, up 12%; funded clients 1.51 million, up 14%
Company repurchased 3.3 million shares for approximately $30 million in the quarter
Skillsoft reported second-quarter fiscal 2027 revenue of $98.2 million, down 3% from a year earlier, while its net loss narrowed 17% to $15.0 million. The company lowered its full-year revenue guidance to $380 million-$390 million from $388 million-$406 million, citing pressure in its consumer business, and kept its Adjusted EBITDA and free cash flow guidance unchanged. The Global Knowledge business was sold to Enduring Ventures in July 2026.
Q2 revenue was $98.2 million, down 3% from $101.2 million a year earlier.
Net loss improved to $15.0 million, or $1.67 per share, from $18.0 million, or $2.10 per share.
Full-year fiscal 2027 revenue guidance was cut to $380 million-$390 million; Adjusted EBITDA ($108 million-$116 million) and free cash flow ($14 million-$22 million) guidance were maintained.
Global Knowledge sale to Enduring Ventures was completed in July 2026.
AEye's Compensation Committee approved a one-time award of 100,000 restricted stock units to Chief Financial Officer Conor Tierney on September 2, 2026, recognizing his work on the Lunar Outpost engagement and the commercial pipeline. The units vest in full on November 15, 2026, if he remains with the company, and each unit settles in one common share, so the award adds potential dilution for shareholders.
Award: 100,000 restricted stock units to CFO Conor Tierney, approved September 2, 2026
Vesting: full vesting on November 15, 2026, subject to continued service
Settlement: each unit that vests converts into one share of AEye common stock
Horizon Funding II, a wholly owned subsidiary of Horizon Technology Finance Corporation (HRZN), signed amendments on September 2, 2026 to its securitization financing documents, including a second supplemental indenture and a second amended and restated note funding agreement. The filing says the amendments extend the Legal Final Payment Date to December 10, 2035, but it does not disclose the size of the notes or any change in interest cost, so the financial effect for shareholders is not quantified.
Amendments dated September 2, 2026 cover the indenture, note funding agreement and sale and servicing agreement for Horizon Funding II, LLC.
The Legal Final Payment Date is extended to December 10, 2035.
The filing references the original indenture dated June 21, 2024 and prior amendments dated May 23, 2025.
The 8-K was signed by CEO Michael P. Balkin on September 9, 2026.
National Rural Utilities Cooperative Finance Corporation (CFC) said it will redeem all $400 million of its 5.60% Medium-Term Notes due 2026 on October 13, 2026, at par plus accrued interest. The company said the redemption is intended to reduce interest expense and will be paid with cash on hand.
Redemption of all $400 million of 5.60% Medium-Term Notes due 2026 (CUSIP 63743HFK3) on October 13, 2026
Notes redeemed at par plus accrued interest
Stated purpose is to reduce interest expense; funded with cash on hand
Notice to investors was provided on September 8, 2026
AeroVironment reported first-quarter fiscal 2027 revenue of $480.5 million, up 6% from a year earlier, and a net loss of $5.1 million, or $0.10 per diluted share, versus a $67.4 million loss a year earlier. The company said it continues to expect full-year fiscal 2027 revenue of $2.125 billion to $2.225 billion and non-GAAP adjusted EBITDA of $305 million to $325 million.
Revenue $480.5 million vs. $454.7 million a year earlier; net loss $5.1 million vs. $67.4 million
Non-GAAP adjusted EBITDA $53.4 million vs. $56.6 million; non-GAAP EPS $0.59 vs. $0.32
Funded backlog $1.5 billion as of August 1, 2026, up 37% year over year; bookings $0.7 billion, book-to-bill 1.4
Full-year fiscal 2027 guidance unchanged: revenue $2.125 billion to $2.225 billion, EPS $0.21 to $0.53
Procore Technologies said it completed its merger with DroneDeploy on September 9, 2026, under a merger agreement first announced July 27, 2026. Procore acquired DroneDeploy for an approximate purchase price of $845.0 million in cash, subject to adjustments for working capital, transaction expenses, cash and indebtedness. The filing gives no financial results for either company, so its effect on Procore's earnings is not stated.
Merger completed September 9, 2026; DroneDeploy is now a wholly-owned subsidiary of Procore
Approximate purchase price of $845.0 million in cash, subject to adjustments
Merger agreement originally entered into July 27, 2026, and reported in an 8-K filed July 29, 2026
Limoneira reported fiscal third-quarter 2026 revenue of $43.8 million, down from $47.5 million a year earlier, and a net loss of $0.17 per diluted share versus $0.06. Adjusted EBITDA rose to $3.9 million from $3.0 million, and the company raised its avocado volume guidance while narrowing lemon volume to the lower end of its range. The company also agreed to sell the Windfall Farms property for $15.0 million in cash, with closing expected September 14, 2026.
Q3 total net revenues were $43.8 million, versus $47.5 million, mainly due to the transition of citrus brokerage operations to Sunkist.
Q3 operating loss was $3.0 million, versus $0.6 million; net loss per diluted share was $0.17, versus $0.06.
Adjusted EBITDA was $3.9 million, versus $3.0 million in the prior-year quarter.
Fiscal 2026 avocado volume guidance raised to 7.0 to 7.25 million pounds; lemon volume expected at the lower end of 4.0 to 4.5 million cartons.
Lee Enterprises' Audit Committee approved dismissing BDO USA, P.C. as its independent auditor on September 2, 2026, after a competitive evaluation tied to a potential audit firm rotation. Grant Thornton LLP was approved as the replacement for the fiscal year ending September 26, 2027, and the change takes effect after BDO completes its fiscal 2026 audit and the company files its annual report.
Audit Committee approved BDO's dismissal on September 2, 2026; the change takes effect after BDO's fiscal 2026 audit and Form 10-K filing.
Grant Thornton LLP approved as auditor for the fiscal year ending September 26, 2027, subject to customary client acceptance procedures.
BDO's reports for fiscal 2025 and 2024 contained no adverse or disclaimer of opinion and were not qualified or modified.
A material weakness in internal controls over certain revenue transactions existed through June 23, 2024 and was remediated as of September 29, 2024.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.